Skip to main content
. 2013 Nov 22;7(2):541–547. doi: 10.3892/ol.2013.1697

Figure 1.

Figure 1

Dose-response curve of cell inhibition of 5-FU on the human LAR-type TNBC cell line, MDA-MB-453. IC10 of 5-FU was 1.47E-07 mol/l. 5-FU, 5-fluorouracil; LAR, luminal androgen receptor; TNBC, triple-negative breast cancer.